1) Yanaka N, Ohata T, Toya K, Kanda M, Hirata A, and Kato N.
Vitamin B6 suppresses serine protease inhibitor 3 expression in the colon of rats and in TNFalpha-stimulated HT-29 cells.
Mol. Nutr. Food Res. 2011, in press.

2) Yanaka N, Kanda M, Toya K, Suehiro H, and Kato N.
Vitamin B6 regulates mRNA expression of peroxisome proliferator-activated receptor- target genes.
Exp. Ther. Med. 2011, in press

3) Okazaki Y, Ohshima N, Yoshizawa I, Kamei Y, Mariggio S, Okamoto K, Maeda M, Nogusa Y, Fujioka Y, Izumi T, Ogawa Y, Shiro Y, Wada M, Kato N, Corda D, and Yanaka N.
A novel glycerophosphodiester phosphodiesterase GDE5 controls skeletal muscle development via a non-enzymatic mechanism.
J. Biol. Chem. 285: 27652-27663, 2010.

4) Kanzaki K, Kuratni M, Mishima T, Matsunaga S, Yanaka N, Usui S, and Wada M.
The effects of eccentric contraction on myofibrillar proteins in rat skeletal muscle.
Eur. J. Appl. Physiol.
110: 943-952, 2010.

5) Dairaku I, Han Y, Yanaka N, and Kato N.
Inhibitory effect of curcumin on IMP dehydrogenase, the target for anticancer and antiviral chemotherapy agents.
Biosci. Biotechnol. Biochem. 4:185-187, 2010.

6) Corda D, Kudo T, Zizza P, Iurisci C, Kawai E, Kato N, Yanaka N*, and Mariggio S*.
The developmentally regulated osteoblast phosphodiesterase GDE3 is glycerophosphoinositol-specific and modulates cell growth.
J. Biol. Chem. 284:24848-24856, 2009. (* corresponding authors)

7) Yanaka N, Kaseda Y, Tanaka A, Nogusa Y, Sumiyoshi N, and Kato N.
Generation of a zinc finger protein ZPR1 mutant that constitutively interacted with translation elongation factor 1alpha.
Biosci. Biotechnol. Biochem. 73:2809-2811, 2009.

8) Hirata T, Fujii M, Akita K, Yanaka N, Ogawa K, Kuroyanagi M, and Hongo D.
Identification and physiological evaluation of the components from citrus fruits as potential drugs for anti-corpulence and anticancer.
Bioorg. Med. Chem. 17:25-28, 2009.

9) Yanaka N, Nogusa Y, Fujioka Y, Yamashita Y, and Kato N.
Involvement of membrane protein GDE2 in retinoic acid-induced neurite formation in Neuro2A cells.
FEBS Lett. 581:712-718, 2007.

10) Yanaka N.
Mammalian glycerophosphodiester phosphodiesterases. (Review)
Biosci. Biotechnol. Biochem. 71:1811-1818, 2007.

11) Mizushina Y, Dairaku I, Yanaka N, Takeuchi T, Ishimaru C, Sugawara F, Yoshida H, and Kato N.
Inhibitory action of polyunsaturated fatty acids on IMP dehydrogenase.
Biochimie. 89:581-590, 2007.

12) Nogusa Y, Yanaka N, Sumiyoshi N, Takeda K, and Kato N.
Expression of zinc finger protein ZPR1 mRNA in brain is up-regulated in mice fed a high-fat diet.
Int. J. Mol. Med. 17:491-496, 2006.

13) Tomotake H, Yamamoto N, Yanaka N, Ohinata H, Yamazaki R, Kayashita J, and Kato N.
High protein buckwheat flour suppresses hypercholesterolemia in rats and gallstone formation in mice by hypercholesterolemic diet and body fat in rats because of its low protein digestibility.
Nutrition. 22:166-173, 2006.

14) Haraguchi T, Yanaka N, Nogusa Y, Sumiyoshi N, Eguchi Y, and Kato N.
Expression of ADP-ribosylation factor-like protein 8B mRNA in the brain is down-regulated in mice fed a high-fat diet.
Biosci. Biotechnol. Biochem. 70:1798-17802, 2006.

15) Yanaka N, Koyama TA, Komatsu S, Nakamura E, Kanda M, and Kato N.
Vitamin B6 suppresses NF-kappaB activation in LPS-stimulated mouse macrophages.
Int. J. Mol. Med. 16:1071-1075, 2005.

16) Komatsu S, Isobe M, Yanaka N, and Kato N.
A high-fat diet enhances the inhibitory effect of dietary vitamin B6 on colon cell proliferation in mice.
Oncol. Rep. 14:265-269, 2005.

17) Nogusa Y, Yanaka N, Sumiyoshi N, Kaseda Y, Tsuboyama-Kasaoka N, Ezaki O, and Kato N.
Short-term feeding of fish oil down-regulates the expression of pyruvate dehydrogenase E1 alpha subunit mRNA in mouse brain.
Biosci. Biotechnol. Biochem. 69 :301-306, 2005.

18) Hashimoto T, Fukunari A, Yamada I, Yanaka N, Chen D, and Kato N.
Y-700, a novel inhibitor of xanthine oxidase, suppresses the development of colon aberrant crypt foci and cell proliferation in 1,2-dimethylhydrazine- treated mice.
Biosci. Biotechnol. Biochem. 69:209-211, 2005.

19) Nogusa Y, Fujioka Y, Komatsu R, Kato N, and Yanaka N.
Isolation and characterization of two serpentine membrane proteins containing glycerophosphodiester phosphodiesterase, GDE2 and GDE6.
Gene. 4:173-179, 2004.

20) Yanaka N, Imai Y, Kawai E, Akatsuka H, Wakimoto K, Nogusa Y, Kato N, Chiba H, Kotani E, Omori K, and Sakurai N.@
Novel membrane protein containing glycerophosphodiester phosphodiesterase motif is transiently expressed during osteoblast differentiation.
J. Biol. Chem. 278:43595-43602, 2003.

21) Yanaka N, Kurosawa Y, Minami K, Kawai E, and Omori K.@
cGMP-phosphodiesterase activity is up-regulated in response to pressure overload of rat ventricles.@
Biosci. Biotechnol. Biochem. 67:973-979, 2003.

22) Komatsu S, Yanaka N, Matsubara K, and Kato N.@
Antitumor effect of vitamin B6 and its mechanisms.@
Biochim. Biophys. Acta. 1647:127-130, 2003.

23) Zhaorigetu S, Yanaka N, Sasaki M, Watanabe H, and Kato N.@
Silk protein, sericin, suppresses DMBA-TPA-induced mouse skin tumorigenesis by reducing oxidative stress, inflammatory responses and endogenous tumor promoter TNF-alpha.
Oncol. Rep. 10:537-543, 2003.

24) Michibata H, Yanaka N, Kanoh Y, Okumura K, and Omori K.
Human Ca(2+)/calmodulin-dependent phosphodiesterase PDE1A: novel splice variants, their specific expression, genomic organization, and chromosomal localization.
Biochim. Biophys. Acta. 1517:278-287, 2001.

25) Wakimoto K, Kuro-o M, Yanaka N, Komuro I, Nabeshima Y, and Imai Y.
Developmental expression of Na+/Ca2+ exchanger (NCX1) gene in the mouse embryo.
Comp. Biochem. Physiol. 130:191-198, 2001.

26) Yanaka N, Kobayashi K, Wakimoto K, Yamada E, Imahie H, Imai Y, and Mori C. 
Insertional mutation of the murine kisimo locus caused a defect in spermatogenesis.
J. Biol. Chem. (Accelrated publication) 275:14791-14794, 2000.

27) Yuasa K, Omori K, and Yanaka N.
Binding and phosphorylation of a novel male germ cell-specific cGMP-dependent protein kinase-anchoring protein by cGMP-dependent protein kinase Ialpha.
J. Biol. Chem. 275:4897-4905, 2000.

28) Wakimoto K, Kobayashi K, Kuro-o M, Yao A, Iwamoto T, Yanaka N, Kita S, Nishida A, Azuma S, Toyoda Y, Omori K, Imahie H, Oka T, Kudoh S, Kohmoto O, Yazaki Y, Nagai R, Shigekawa M, Imai1 Y, Nabeshima Y, and Komuro I.
Targeted disruption of Na+/Ca2+ exchanger gene leads to cardiomyocyte apoptosis and defects in heartbeat.
J. Biol. Chem. 275:36991-36998, 2000.

29) Yuasa K, Michibata H, Omori K, and Yanaka N. 
Identification of a conserved residue responsible for the autoinhibition of cGMP-dependent protein kinase Ialpha and beta.
FEBS Lett. 466:175-178, 2000.

30) Yuasa K, Omori K, and Yanaka N. 
The specific domain of cGMP -dependent protein kinase Ibeta but not Ialpha functions as a transcriptional activator in yeast.
IUBMB Life. 49:17-22, 2000.

31) Wakimoto K, Kuro-o M, Yanaka N, Omori O, Komuro I, Imai Y, and Nabeshima Y.
Isolation and characterization of Na+/Ca2+ exchanger gene and splicing isoforms in mice.
DNA Seq.
11:75-81, 2000.

32) Yuasa K, Michibata H, Omori K, and Yanaka N.
A novel interaction of cGMP-dependent protein kinase I with troponin T.
J. Biol. Chem. 274:37429-37434, 1999.

33) Kotera J, Fujishige K, Imai Y, Kawai E, Michibata H, Akatsuka H, Yanaka N, and Omori K. 
Genomic origin and transcriptional regulation of two variants of cGMP-binding cGMP-specific phosphodiesterases.
Eur. J. Biochem. 262:866-873, 1999.

34) Fujishige K, Kotera J, Yanaka N, Akatsuka H, and Omori K.
Alteration of cGMP metabolism during chondrogenic differentiation of chondroprogenitor-like EC cells, ATDC5.
Biochim. Biophys. Acta. 1452:219-227, 1999.

35) Kotera J, Fujishige K, Akatsuka H, Imai Y, Yanaka N, and Omori K. 
Novel alternative splice variants of cGMP-binding cGMP-specific phosphodiesterase.
J. Biol. Chem. 273:26982-26990, 1998.

36) Yanaka N, Akatsuka H, Kawai E, and Omori K.
1,25-Dihydroxyvitamin D3 upregulates natriuretic peptide receptor-C expression in mouse osteoblasts.
Am. J. Physiol. 275:E965-973, 1998.

37) Yanaka N, Kotera J, Ohtsuka A, Akatsuka H, Imai Y, Michibata H, Fujishige K, Kawai E, Takebayashi S, Okumura K, and Omori K.                            
Expression, structure and chromosomal localization of the human cGMP-binding cGMP-specific phosphodiesterase PDE5A gene.
Eur. J. Biochem. 255:391-399, 1998.

38) Yanaka N, Kotera J, and Omori K. 
Isolation and characterization of the 5'-flanking regulatory region of the human natriuretic peptide receptor C gene.
Endocrinology 139:1389-1400, 1998.

39) Fujishige K, Yanaka N, Akatsuka H, and Omori K. 
Localization of clearance receptor in rat lung and trachea: association with chondrogenic differentiation.
Am. J. Physiol. 274:L425-431, 1998.

40) Koguchi Y, Asai Y, Suzuki S, Nishio M, Yanaka N, Omori K, Ohnuki T, and Komatsubara S. 
TMC-49A, a novel transcriptional up-regulator of low density lipoprotein receptor, produced by Streptomyces sp. AS1345.
J Antibiot (Tokyo). 51:107-111, 1998.

41) Yanaka N, Akatsuka H, and Omori K. 
Protein kinase C activation down-regulates natriuretic peptide receptor C expression via transcriptional and post-translational pathways.
FEBS Lett. 418:333-336, 1997.

42) Kotera J, Yanaka N, Fujishige K, Imai Y, Akatsuka H, Ishizuka T, Kawashima K, and Omori K. 
Expression of rat cGMP-binding cGMP-specific phosphodiesterase mRNA in Purkinje cell layers during postnatal neuronal development.
Eur. J. Biochem. 249:434-442, 1997.

43) Yanaka N, Kotera J, Taguchi I, Sugiura M, Kawashima K, and Omori K.
Structure of the 5'-flanking regulatory region of the mouse gene encoding the clearance receptor for atrial natriuretic peptide.
Eur. J. Biochem. 237:25-34, 1996.